PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies ...

ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present preclinical data for its proprietary Axiomer™ ...

The FDA has granted Fast Track designation to zilganersen for the treatment of Alexander disease, a rare type of leukodystrophy.

A new RNAi biotech is breaking ground with $135 million and John Maraganore, Ph.D., holding the key to the city. | A new RNAi ...

A study led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) has developed a new ...

"FDA gives Adcendo green light to trial ADC in Phase I/II sarcoma study" was originally created and published by Clinical ...

Moreover, CBS reported that Hurricane Helene is projected to be one of the most expensive storms in U.S. history, with ...

VisionVentionstm, a pioneering ophthalmic device company, has launched its operations with a commitment to addressing niche, unmet needs in ophthalmic surgery. The company is set to transform the ...

Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision ...

Mitochondrial myopathies caused by diverse mitochondrial stressors, including mitochondrial DNA (mtDNA) depletion or ...